Humanized anti-complement factor Bb antibodies
US11242382B2 · kind B2 · utility
2Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 19, 2021 |
| Grant date | Feb 8, 2022 |
| Priority date | — |
| Expiry date | Apr 19, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are humanized anti-factor Bb antibodies, methods of producing the antibodies and methods of using the antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.